Retatrutide is in Phase 3 trials for type 2 diabetes (TRANSCEND-T2D program), obstructive sleep apnea, metabolic dysfunction-associated steatotic liver disease, chronic kidney disease in patients with type 2 diabetes, knee osteoarthritis, and cardiovascular outcomes [1][8][10][11]
R., Gao, L., et al
population (38.4 million), with 38% of adults (97.6 million) having prediabetes
The Treatment Experience When you visit us for a session, here is what you can expect: Consultation: Well discuss your skin goals and medical history
Thats why its critical to plan with your doctor, because it really comes down to your specific situation
thelancet.com Buckley ST, Baekdal TA, Vegge A, et al